DENINTUZUMAB MAFODOTIN

UNII:	H5324S1M7H
Formula:
Preferred Substance Name:	DENINTUZUMAB MAFODOTIN

1399672-02-6
DENINTUZUMAB MAFODOTIN [INN]
DENINTUZUMAB MAFODOTIN [USAN]
DENINTUZUMAB MAFODOTIN [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD19 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL HBU12 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HBU12 .KAPPA.-CHAIN, DIMER, TETRAKIS(THIOETHER) WITH N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)-N-METHYL-L-VALYL-L-VALYL-(3R,4S,5S)-3-METHOXY-5-METHYL-4-(METHYLAMINO)HEPTANOYL- (.ALPHA.R,.BETA.R,2S)-.BETA.-METHOXY-.ALPHA.-METHYL-2-PYRROLIDINEPROPANOYL-L-PHENYLALANINE
IMMUNOGLOBULIN G1-KAPPA AURISTATIN F CONJUGATE, ANTI-(HOMOSAPIENS CD19 (B LYMPHOCYTE SURFACE ANTIGEN B4, LEU-12)), HUMANIZED MONOCLONAL ANTIBODY
SGN-19A
SGNCD19A
SGN-CD19A

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

DENINTUZUMAB MAFODOTIN

Synonyms and Mappings

Resources